Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venrock
Biotech
AIRNA preps for clinical test with $155M series B
AIRNA's tech makes targeted adenosine-to-inosine edits in RNA, which the firm hopes can provide a functional cure for alpha-1 antitrypsin deficiency.
Darren Incorvaia
Apr 1, 2025 7:00am
ADC biotech adds on $135M series B
Nov 25, 2024 7:00am
Paragon spinout Apogee makes debut with $169M
Dec 7, 2022 6:30am
Ocelot Bio gets a cool $36M series A and a new CEO to boot
Mar 23, 2022 8:30am
